Jellagen Private
Jellagen is a medtech company that specializes in offering high-grade native collagen sourced from jellyfish. Their collagen-based innovation addresses complex tissue engineering and regenerative medical needs, making it ideal for next-generation medical treatments and scientific research. Jellagen's collagen is compatible with a broad range of cell types and is a versatile biomaterial for tissue engineering and regenerative medicine. Derived from jellyfish, their collagen avoids religious and safety concerns associated with mammalian collagen and disease transfer. With a proprietary extraction technique, Jellagen maintains the characteristic triple helix structure of collagen, making it suitable for in-vitro and in-vivo studies.
Technology:
Stem Cells (Regenerative Medicine)
Headquarters:
Pembroke Dock, Pembrokeshire, United Kingdom
Founded Date:
2013
Number Of Exists:
Series B
Employee Number:
15
Industry:
Stem Cells (Regenerative Medicine)